Sugi Predict

Sugi Predict / Compounds / SCHEMBL722389

SCHEMBL722389

SCHEMBL722389

COC(C(=O)O)C(O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC1A3 P43003 1/20 0.54
▸ SLC1A2 P43004 1/20 0.54
▸ SLC1A1 P43005 1/20 0.54
▸ TSHR P16473 3/20 0.47
▸ TP53 P04637 1/20 0.38
▸ PGD P52209 2/20 0.35
▸ MMP1 P03956 1/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ MMP3 P08254 1/20 0.32
▸ MMP9 P14780 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ NFKB1 P19838 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290471 1.00 SLC1A3 (0.54) SLC1A3SLC1A2SLC1A1TSHRTP53
SCHEMBL7291825 1.00 SLC1A3 (0.54) SLC1A3SLC1A2SLC1A1TSHRTP53
SCHEMBL27742181 0.97 SLC1A3 (0.52) SLC1A3SLC1A2SLC1A1TSHRTP53
Ethylene Glycol SCHEMBL3744577 0.91 SLC1A3 (0.46) SLC1A3SLC1A2SLC1A1TSHRTP53
Propylene Glycol SCHEMBL3726880 0.87 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1TSHRTP53
1,4-Butanediol SCHEMBL3733977 0.87 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1TSHRPGD
Di(Hydroxyethyl)Ether SCHEMBL3746401 0.83 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1TSHRPGD
SCHEMBL8780658 0.82 TSHR (0.41) SLC1A3SLC1A2SLC1A1TSHRTP53
SCHEMBL12610812 0.82 SLC1A3 (0.48) SLC1A3SLC1A2SLC1A1TSHRTP53
SCHEMBL12610806 0.82 SLC1A3 (0.48) SLC1A3SLC1A2SLC1A1TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11872234-B2 Vareniciline compound and process of manufacture thereof PAR PHARMACEUTICAL, INC. (US) 2024-01-16 — — US claimed
US-11779587-B2 Vareniciline compound and process of manufacture thereof PAR PHARMACEUTICAL, INC. (US) 2023-10-10 — — US claimed
US-20230285407-A1 VARENICILINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT 2023-09-14 — — US claimed
US-20230285406-A1 VARENICILINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT 2023-09-14 — — US claimed
CN-116370326-A Composition for reinforcing keratin fibres 威娜德国有限责任公司 2023-07-04 — — CN claimed
CN-113264932-A Preparation method of zolpidem 湖南千金湘江药业股份有限公司 2021-08-17 — — CN claimed
CN-107245038-A A kind of method for splitting of amino butanol 嘉兴润博化工科技有限公司 2017-10-13 — — CN claimed
CN-106892881-A A kind of method of selectivity synthesis diltiazem chiral intermediate 郭彦超 2017-06-27 — — CN claimed
WO-2024114793-A1 SALT FORM AND CRYSTAL FORM OF UBIQUITINATION-SPECIFIC PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州普济远成生物医药科技有限公司 2024-06-06 — — WO disclosed
EP-4241775-A1 TABLET COMPRISING VARENICLINE AND PROCESS OF PREPARATION THEREOF Par Pharmaceutical, Inc. (US) 2023-09-13 — — EP disclosed
CN-116370326-A Composition for reinforcing keratin fibres 威娜德国有限责任公司 2023-07-04 — — CN disclosed
CN-109705090-B Tartaric acid addition salts of 3, 4-disubstituted 1H-pyrazole compounds and crystalline forms thereof 上海君实生物医药科技股份有限公司 2023-06-20 — — CN disclosed
CN-116096713-A Solid forms of the compounds 应世生物科技(南京)有限公司 2023-05-09 — — CN disclosed
CN-113264932-B Preparation method of zolpidem 湖南千金湘江药业股份有限公司 2022-06-14 — — CN disclosed
US-5006522-A Vagal pacemaker for treatment of bradycardia or radyarrhythmia KARL THOMAE GMBH (DE) 1991-04-09 — — US disclosed
EP-0416885-A1 Vulcanizable epoxy group-containing elastomer composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-03-13 — — EP disclosed
US-4992544-A Intermediates for b-lactam antibiotics and b-lactamase inhibitor UNIVERSITY OF NOTRE DAME DU LAC (US) 1991-02-12 — — US disclosed
US-4912115-A Cardiovascular disorders DR. KARL THOMAE GMBH (DE) 1990-03-27 — — US disclosed
US-4871735-A HYPOTENSIVE, ANTIISCHEMIC AGENTS DR. KARL THOMAE GMBH 1989-10-03 — — US disclosed
US-4567178-A ANTIULCER AGENTS DR. KARL THOMAE GMBH (DE) 1986-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230285407-A1 VARENICILINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF COMT, CYP2C9, CYP3A7 SLC1A3 3942/4885SLC1A2 2622/4885SLC1A1 3207/4885
US-11779587-B2 Vareniciline compound and process of manufacture thereof COMT, CYP2C9, CYP3A7 SLC1A3 3942/4885SLC1A2 2622/4885SLC1A1 3207/4885
US-11872234-B2 Vareniciline compound and process of manufacture thereof COMT, CYP2C9, CYP3A7 SLC1A3 3942/4885SLC1A2 2622/4885SLC1A1 3207/4885
US-20230285406-A1 VARENICILINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF COMT, CYP2C9, CYP3A7 SLC1A3 3942/4885SLC1A2 2622/4885SLC1A1 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.